Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
7/23/24 Shionogi (4507) Xocova for COVID-19 Treatment Subscribers Only Subscribers Only Subscribers Only
7/22/24 Gan & Lee GZR18 for Obesity Subscribers Only Subscribers Only Subscribers Only
7/18/24 Paratek Nuzyra for Community Acquired Pneumonia (CAP) (Antibacterial) Subscribers Only Subscribers Only Subscribers Only
7/18/24 LG Chem (051910:KS) Fotivda for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only
7/16/24 Orexo (ORX) OX124 for Opioid Use Disorder Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
01/01/25 - 04/30/24 Subscribers Only Subscribers Only Progress Update - Product Launch
07/25/24 Subscribers Only Subscribers Only Regulatory - FDA Advisory Panel Meeting
07/25/24 Subscribers Only Subscribers Only Trial Data - Updated Results
Now - 07/26/24 Subscribers Only Subscribers Only Regulatory - Approval Decision (Europe)
Now - 07/26/24 Subscribers Only Subscribers Only Progress Update - Product Launch (U.S.)